Expression of Inflammatory and Regenerative Genes in a Model of Liver Ischemia/Reperfusion and Partial Hepatectomy

Journal of Investigative Surgery

Volumn 29, Issue 2, 2016, Pages 67-73

  Athanasopoulos, Panagiotis ^a   Mastoraki, Aikaterini ^b   Papalois, Apostolos ^c   Nastos, Constantinos ^b   Kondi Pafiti, Agathi ^d   Kostopanagiotou, Georgia ^b   Smyrniotis, Vassilios ^b   Arkadopoulos, Nikolaos ^b  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c Experimental Research Center ELPEN   (Greece)

^d UNIVERSITY OF ATHENS   (Greece)

Author keywords

hepatectomy; inflammatory genes; liver ischemia; porcinemodel; regenerative capacity; reperfusion

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN GLUCURONIDE; CREATININE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; LACTATE DEHYDROGENASE; LACTIC ACID; MESSENGER RNA; STAT3 PROTEIN; TRANSFORMING GROWTH FACTOR ALPHA; UREA; BILIRUBIN;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BLOOD SAMPLING; CONTROLLED STUDY; DISEASE SEVERITY; DISSE SPACE; FEMALE; GENE EXPRESSION; HEPATITIS; LANDRACE PIG; LIVER BIOPSY; LIVER ISCHEMIA; LIVER LOBULE; LIVER REGENERATION; MITOSIS INDEX; NONHUMAN; OPERATIVE BLOOD LOSS; PARTIAL HEPATECTOMY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REPERFUSION INJURY; RNA ISOLATION; ADVERSE EFFECTS; ANIMAL; BIOPSY; BLOOD; DISEASE MODEL; INFLAMMATION; ISCHEMIA; LIVER; LIVER DISEASE; LIVER RESECTION; METABOLISM; PATHOLOGY; PIG;

ALANINE TRANSAMINASE; ALKALINE PHOSPHATASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; BILIRUBIN; BIOPSY; DISEASE MODELS, ANIMAL; E-SELECTIN; FEMALE; HEPATECTOMY; INFLAMMATION; INTERLEUKIN-1BETA; INTERLEUKIN-6; ISCHEMIA; LIVER; LIVER DISEASES; LIVER REGENERATION; NITRIC OXIDE SYNTHASE TYPE II; REPERFUSION INJURY; RNA, MESSENGER; STAT3 TRANSCRIPTION FACTOR; SWINE; TRANSFORMING GROWTH FACTOR ALPHA;

EID: 84941729696     PISSN: 08941939     EISSN: 15210553     Source Type: Journal    
DOI: 10.3109/08941939.2015.1060280     Document Type: Article

References (47)

1. Mullen JT, Ribero D, Reddy SK, et al. Hepatic insufficiency and mortality in 1,059 noncirrhotic patients undergoing major hepatectomy. J Am Coll Surg. 2007; 204: 854-862.
2. Ho CK, Lee CW, Lu J, et al. New hope for an old cure: a pilot animal study on selective venesection in attenuating the systemic effects of ischaemic-reperfusion injury. Ann Acad Med Singapore. 2009; 38: 569-575.
3. Abu-Amara M, Gurusamy K, Hori S, et al. Systematic review of randomized controlled trials of pharmacological interventions to reduce ischaemia-reperfusion injury in elective liver resection with vascular occlusion. HPB. 2010; 12: 4-14.
4. Arkadopoulos N, Defterevos G, Nastos C, et al. Development of a porcine model of post-hepatectomy liver failure. J Surg Res. 2011; 170: e233-242.
5. Perry BC, Soltys D, Toledo AH, et al. Tumor necrosis factor-a in liver ischemia/reperfusion injury. J Invest Surg. 2011; 24: 178-188.
6. Phillips L, Toledo AH, Lopez-Neblina F, et al. Nitric oxide mechanism of protection in ischemia and reperfusion injury. J Invest Surg. 2009; 22: 46-55.
7. Feindel CM, Harper R, Wallace AC, et al. Tolerance of the liver to ischemia: an experimental study. Can J Surg. 1981; 24: 147-149.
8. Prieto-Moure B, Carabén-Redaño A, Aliena-Valero A, et al. Allopurinol in renal ischemia. J Invest Surg. 2014; 27: 304-316.
9. Jalan R, O Damink SW, Deutz NE, et al. Moderate hypothermia for uncontrolled intracranial hypertension in acute liver failure. Lancet. 1999; 354: 1164-1168.
10. van de Kerkhove MP, Hoekstra R, et al. Large animal models of fulminant hepatic failure in artificial and bioartificial liver support research. Biomaterials. 2004; 25: 1613-1625.
11. Suzuki S, Nakamura S, Sakaguchi T, et al. Pathophysiological appraisal of a rat model of total hepatic ischemia with an extracorporeal portosystemic shunt. J Surg Res. 1998; 80: 22-27.
12. Unno N, Uchiyama T, Yamamoto N, et al. Portal triad occlusion induces endotoxin tolerance: role of portal congestion. J Surg Res. 2006; 135: 213-217.
13. Hochleitner B, Hengster P, Bucher H, et al. Significant survival prolongation in pigs with fulminant hepatic failure treated with a novel microgravity-based bioartificial liver. Artif Organs. 2006; 30: 906-914.
14. Wang H, Ohkohchi N, Enomoto Y, et al. Effect of portocaval shunt on residual extreme small liver after extended hepatectomy in porcine. World J Surg. 2006; 30: 2014-2022.
15. Ytrebø LM, Nedredal GI, Langbakk B, et al. An experimental large animal model for the assessment of bioartificial liver support systems in fulminant hepatic failure. Scand J Gastroenterol. 2002; 37: 1077-1088.
16. Ochiai H, Nakamura S, Suzuki S, et al. Pancreatic damage resulting from temporary portal triad interruption during partial hepatectomy: protective effect of a prostaglandin I2 analogue. J Surg Res. 1997; 73: 129-136.
17. Garcia-Pagán JC, Zhang JX, Sonin N, et al. Ischemia/reperfusion induces an increase in the hepatic portal vasoconstrictive response to endothelin-1. Shock. 1999; 11: 325-329.
18. Marubashi S, Sakon M, Nagano H, et al. Effect of portal hemodynamics on liver regeneration studied in a novel portohepatic shunt rat model. Surgery. 2004; 136: 1028-1037.
19. Abu-Amara M, Yang SY, Tapuria N, et al. Liver ischemia/reperfusion injury: processes in inflammatory networks-a review. Liver Transpl. 2010; 16: 1016-1032.
20. Fausto N. Liver regeneration. J Hepatol. 2000; 32: 19-31.
21. Koniaris LG, McKillop IH, Schwartz SI, et al. Liver regeneration. J Am Coll Surg. 2003; 197: 634-659.
22. Teoh N, Field J, Farrell G. Interleukin-6 is a key mediator of the hepatoprotective and pro-proliferative effects of ischaemic preconditioning in mice. J Hepatol. 2006; 45: 20-27.
23. Fausto N, Campbell JS, Riehle KJ. Liver regeneration. Hepatology. 2006; 43: S45-53.
24. Stepniak E, Ricci R, Eferl R, et al. c-Jun/AP-1 controls liver regeneration by repressing p53/p21 and p38 MAPK activity. Genes Dev. 2006; 20: 2306-2314.
25. Li W, Liang X, Kellendonk C, et al. STAT3 contributes to the mitogenic response of hepatocytes during liver regeneration. J Biol Chem. 2002; 277: 28411-28417.
26. Behrens A, Sibilia M, David JP, et al. Impaired postnatal hepatocyte proliferation and liver regeneration in mice lacking c-jun in the liver. EMBO. J 2002; 21: 1782-1790.
27. Hafez T, Moussa M, Nesim I, et al. The effect of intraportal prostaglandin E1 on adhesion molecule expression, inflammatory modulator function, and histology in canine hepatic ischemia/reperfusion injury. J Surg Res. 2007; 138: 88-99.
28. Peralta C, Fernández L, Panés J, et al. Preconditioning protects against systemic disorders associated with hepatic ischemia-reperfusion through blockade of tumor necrosis factor-induced P-selectin up-regulation in the rat. Hepatology. 2001; 33: 100-113.
29. Schwabe RF, Brenner DA. Mechanisms of Liver Injury. I. TNF-alpha-induced liver injury: role of IKK, JNK, and ROS pathways. Am J Physiol Gastrointest Liver Physiol. 2006; 290: 583-589.
30. Rajesh M, Pan H, Mukhopadhyay P, et al. Cannabinoid-2 receptor agonist HU-308 protects against hepatic ischemia/reperfusion injury by attenuating oxidative stress, inflammatory response, and apoptosis. J Leukoc Biol. 2007; 82: 1382-1389.
31. Scotté M, Masson S, Lyoumi S, et al. Cytokine gene expression in liver following minor or major hepatectomy in rat. Cytokine. 1997; 9: 859-867.
32. Hallbeck AL, Walz TM, Wasteson A. Interleukin-6 enhances transforming growth factor-alpha mRNA expression in macrophage-like human monocytoid (U-937-1) cells. Biosci Rep. 2001; 21: 325-339.
33. Tomiya T, Ogata I, Fujiwara K. Transforming growth factor alpha levels in liver and blood correlate better than hepatocyte growth factor with hepatocyte proliferation during liver regeneration. Am J Pathol. 1998; 153: 955-961.
34. Mitchell C, Nivison M, Jackson LF, et al. Heparin-binding epidermal growth factor-like growth factor links hepatocyte priming with cell cycle progression during liver regeneration. J Biol Chem. 2005; 280: 2562-2568.
35. Fausto N, Laird AD, Webber EM. Liver regeneration. 2. Role of growth factors and cytokines in hepatic regeneration. FASEB J. 1995; 9: 1527-1536.
36. Sowa JP, Best J, Benko T, et al. Extent of liver resection modulates the activation of transcription factors and the production of cytokines involved in liver regeneration. World J Gastroenterol. 2008; 14: 7093-7100.
37. Lowes KN, Croager EJ, Olynyk JK, et al. Oval cell-mediated liver regeneration: Role of cytokines and growth factors. J Gastroenterol Hepatol. 2003; 18: 4-12.
38. Mangnall D, Bird NC, Majeed AW. The molecular physiology of liver regeneration following partial hepatectomy. Liver Int. 2003; 23: 124-138.
39. Caban A, Oczkowicz G, Abdel-Samad O, et al. Influence of Kupffer cells on the early phase of liver reperfusion. Transplant Proc. 2002; 34: 694-697.
40. Llacuna L, Mari M, Lluis JM, et al. Reactive oxygen species mediate liver injury through parenchymal nuclear factor-kappaB inactivation in prolonged ischemia/reperfusion. Am J Pathol. 2009; 174: 1776-1785.
41. Hsu CM, Wang JS, Liu CH, et al. Kupffer cells protect liver from ischemia-reperfusion injury by an inducible nitric oxide synthase-dependent mechanism. Shock. 2002; 17: 280-285.
42. Hamada T, Duarte S, Tsuchihashi S, et al. Inducible nitric oxide synthase deficiency impairs matrix metalloproteinase-9 activity and disrupts leukocyte migration in hepatic ischemia/reperfusion injury. Am J Pathol. 2009; 174: 2265-2277.
43. Wang LM, Tian XF, Song QY, et al. Expression and role of inducible nitric oxide synthase in ischemia-reperfusion liver in rats. Hepatobiliary Pancreat Dis Int. 2003; 2: 252-258.
44. Newsome PN, Plevris JN, Nelson LJ, et al. Animal models of fulminant hepatic failure: a critical evaluation. Liver Transpl. 2000; 6: 21-31.
45. Filipponi F, Fabbri LP, Marsili M, et al. A new surgical model of acute liver failure in the pig: experimental procedure and analysis of liver injury. Eur Surg Res. 1991; 23: 58-64.
46. Gao Y, Mu N, Xu XP, et al. Porcine acute liver failure model established by two-phase surgery and treated with hollow fiber bioartificial liver support system. World J Gastroenterol. 2005; 11: 5468-5474.
47. Ladurner R, Hochleitner B, Schneeberger S, et al. Extended liver resection and hepatic ischemia in pigs: a new, potentially reversible model to induce acute liver failure and study artificial liver support systems. Eur Surg Res. 2005; 37: 365-369.